Author Correspondence author
Molecular Microbiology Research, 2012, Vol. 2, No. 1 doi: 10.5376/mmr.2012.02.0001
Received: 29 Oct., 2012 Accepted: 05 Nov., 2012 Published: 25 Dec., 2012
Modi et al., 2012, A Comprehensive Review on Pharmacotherapeutics of Bovine Mastitis, Molecular Microbiology Research, Vol.2, No.1 1-9 (doi: 10.5376/mmr.2012.02.0001)
In 1926 land has first time reported records of mastitis in India. Mastitis is defined as inflammatory reaction of parenchyma of mammary gland that can be of infectious, traumatic or toxic nature. Mastitis is one the most prevalent disease of dairy animals characterized by pathological changes in glandular tissues of udder and physical, chemical and microbiological changes in milk. More than 100 different microorganisms can cause mastitis, and these vary greatly in the route by which they reach the cow and the nature of the disease they cause. The disease is most common cause of antimicrobial agent use on dairy farms. In USA one study has indicated 82% of antibiotic residue violations were related to the treatment of mastitis. In on basis of effects on productivity, international trade animal warfare and zoonotic risk mastitis was ranked highest above all other infectious diseases such as salmonellosis, Para tuberculosis and bovine viral diarrheoa. The present paper describes the detailed account of antimicrobial use and treatment decisions for mastitis in bovine include the return of the cow to normal milk production and composition, prevention of mortality in peracute cases, elimination of infectious microorganisms, and elimination of practices that may lead to drug residues in milk or meat.
. PDF(182KB)
. FPDF(win)
. HTML
. Online fPDF
Associated material
. Readers' comments
Other articles by authors
. Chirag Modi
. Hitesh Patel
. H Patel
. Shailesh Mody
Related articles
. Pharmacotherapeutics
. Bovine
. mastitis
Tools
. Email to a friend
. Post a comment